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A new analytical approach using matrix-assisted laser desorption/ionization mass spectrom-
etry imaging (MALDI MSI) for the study of honeybee venom is shown. In vitro and in vivo
models simulating the bee sting have been developed using live honeybees and, as the
envenomation sites, pig ears and rat legs; MALDI MSI has been used to map, over time, the
diffusion and distribution of three venom allergens (Api m 1, Api m 4, and Api m 6) and two
venom toxins (apamine and mast cell degranulating peptide). In conjunction with other
classical biochemical techniques and high resolution mass spectrometry (HRMS), structural
data have been obtained that contribute to current understanding of honeybee venom
composition. Initial data have also been obtained demonstrating the feasibility of mapping the
organism’s response to the sting. The opportunity to monitor venom diffusion and the
organism’s response at the same time might open new pathways for in vivo preclinical studies
in designing and testing new venom immunotherapy (VIT). (J Am Soc Mass Spectrom 2009,
20, 112–123) © 2009 Published by Elsevier Inc. on behalf of American Society for Mass
SpectrometryThe study of hymenoptera venom is important, asit can trigger allergic reactions in humans that canbe fatal. In particular, venom from European
honeybees (Apis mellifera) is reported to be the best
characterized of all insect venoms [1, 2]; nonetheless,
current literature demonstrates that this topic is cur-
rently of widespread scientific interest. When threat-
ened, honeybees deliver the venom through a peculiar
barbed sting designed to remain embedded in the
victim’s flesh [3]. Axial movements of the two barbed
stylets causes further burying of the sting over a period
of 30 s [4]. Once the sting is fully embedded, the
venom discharge starts. Honeybee venom (HBV) is
composed of a wide spectrum of biomolecules, ranging
from biogenic amines to peptides and proteins, whose
structure and function have been determined [5–8]; full
characterization of venom components, including func-
tion, synergistic mechanisms in the toxic reaction, cross-
reactivity, and the range of biomolecules released upon
envenomation, is crucial for the elucidation of HBV
action and therefore currently under investigation by a
number of research groups [9–11]. The disclosure of
this information would have considerable impact on
current venom immunotherapy (VIT) by allowing tai-
loring of the therapeutic treatment of an individual’s
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ported that VIT with recombinant HBV allergens, as-
sayed in stage I clinical trials, was more specific and
safer than treatments employing bee-derived venom
[9]. A full venom characterization would also help to
possibly improve current HBV based therapeutics, re-
ported in particular for arthritic and rheumatic condi-
tions [12].
The reaction to HBV (and to hymenoptera in general)
can be of an allergic and/or toxic nature. Allergens are
generally proteins (enzymes) and may trigger life
threatening and sometimes fatal IgE-mediated anaphy-
lactic reactions. Toxins are generally peptides and cause
localized reactions. An exception to these groupings can
be made for melittin, which is a peptidic allergen.
The regulation of IgE synthesis is mediated by the
release of small molecules like histamine, sulfidoleukot-
rienes (LTC4, LDT4, LTE4, LTA4) and proteins such as
cytokines. Th-2 profile cells produce interleukin-13 and
interleukin-4, which promote IgE synthesis by B cells,
whereas Th-1 cells produce IFN-, which prevents
hypersensitivity by playing a negative regulatory role
in the development of Th2 cells [13]. Diagnosis of
IgE-mediated insect venom allergy by classical allergen-
specific IgE tests is often not reliable; tests detecting
release of sulfidoleukotrienes such as the CAST-ELISA
may therefore be a valid alternative [14].
The International Union of Immunological Societies
(IUIS) reports the list of honeybee venom allergens
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allergen.org/Allergen.aspx). There are six officially rec-
ognized venom allergens: phospholipase A2 (Api m 1),
hyaluronidase (Api m 2), acid phosphatase (Api m 3),
melittin (Api m 4), a newly discovered small protein
Api m 6, and the CUB serine protease (Api m 7).
Api m1 is the most characterized honeybee venom
allergen and is reported to account for 10% to 12% of
crude venom [12]. The primary amino sequence of the
mature protein has a MW of 15.2 kDa. The enzyme is
also present in glycosylated isoforms, which are not yet
extensively characterized for their microheterogeneity
[15]. Nevertheless, it is known that the glycostructures
are N-linked to asparagine 13 [16], giving rise to higher
molecular weight species. The allergenic actions of Api
m 1 are a result of scavenging actions on biological
membranes, disrupting the main conformation and
producing lysophospholipids as well as long-chain an-
ionic fatty acids. Many studies have reported a syner-
gistic activity with melittin, where the latter would
open membrane channels leading to the exposure of the
phospholipid catalytic site of Api m 1 [3, 12].
Api m 2 is also a very important allergen accounting
for 1% to 2% of the crude venom [3]. Its molecular
weight ranges from 40.7 kDa (primary amino acidic
sequence) to 60 kDa [13], depending on the carbohy-
drate content N-linked to the protein. Api m 2 is called
the “spreading factor” because it disrupts hyaluronic
acid connective tissue matrix allowing other allergens
and toxins to infiltrate and spread in the tissue [3]. Api
m 3 is a glycoprotein accounting for 1% to 2% of the
venom dry weight [3, 13]. In 2005, this protein was
reported by Peiren and coworkers [9] to have been
removed from the list of allergens because of incom-
plete IgE binding and lack of satisfactory sequence data.
Nonetheless, the IUIS has re-introduced this enzyme
into the allergen list. This is probably due to the studies
of Grunwald and coworkers [8] as well as Hoffman and
collaborators [17, 18] who determined by several means
its molecular weight (43.9 kDa, processed primary
amino acid sequence) and its IgE binding capacity as a
major allergen. Although the biological mechanism of
action is not fully elucidated, the deduced amino acid
sequence for Api m 3 exhibits several features in
common with high molecular weight phosphatases,
which hydrolyze phosphomonoesters in a two step
mechanism involving a histidine at the active site [8].
Api m 4, a basic peptide of 26 residues (2.8 kDa), is
considered a minor allergen and accounts for 45% to
50% of the venom dry weight [12, 19]. Api m 4 exhibits
an amphipathic structure; its polar and nonpolar ends
allow it to interact with lipid membranes and ultimately
increases permeability. In particular, its tetrameric
structure has been suggested to act as an ionophoretic
scavenger. This property would be responsible for
skeletal muscle, heart, and blood vessel contraction as
well as nerve depolarization, with the latter macroscop-
ically translating into the intense pain caused by the
sting. Api m 6 was isolated and fully characterized forthe first time in 2001 by Kettner and coworkers [20],
who found it to bind to IgE antibodies in greater than
40% to 42% of bee venom hypersensitive patients, thus
making it a minor allergen [20, 21]. Api m 6 accounts for
1% to 2% of the crude venom, with four isoforms in
equimolar amounts and with the same allergenicity
[20]. The four isoforms, named Api m 6.01 to Api m
6.04, share a common central amino acid sequence of 67
residues and differ only in their amino and carboxy-
terminus by up to 6 amino acids. API m 6.01 and Api m
6.03, with five disulphide bridges, have a molecular
weight of 7179.6 (5–71) and 7588.1 Da (1–71). The
isoforms, Api m 6.02 and 6.04 exhibit an extra two
amino acids at the carboxy-terminus (leucine and pro-
line, not necessarily in this order) so that their molecu-
lar weights are 7389.9 (5–73), and 7798.3 Da (1–73).
respectively [20]. Reasons for the presence of these
isoforms have been described by Perein and collabora-
tors. In their work, Api m 6 is shown to derive from a
single locus, but the protein level variation is caused by
it sitting near a misassembled section of the honeybee
genome sequence. The authors proposed that a substan-
tial number of indels at and near Api m 6 might be the
reason for this misassembly. Although it is known to
bind to IgE, a fundamental knowledge of its biological
activity is still unknown. Api m 7 is the last known bee
venom protein allergen. It was first reported by Shken-
derov et al. in 1973 [22] as an allergenic protein of 39
kDa. It was then detected by other laboratories [23–26],
and shown to contain a typical tryptic protease domain
with a serine protease catalytic triad. Despite not being
reported in the official allergen list, the newly discov-
ered HBV Icarapin (MW 19.6 kDa) [9] is a glycoprotein
worth mentioning along with the other allergens, as it
has been cloned, expressed and found to bind IgE [10].
Concerning venom bioactivity, it is important to also
mention two peptides, which are not allergens but are
considered major venom toxins: apamine and mast cell
degranulating (MCD) peptide. Apamine is a small 18
amino acids (MW 2.0 kDa) well characterized peptide
accounting for less than 2% of venom dry weight. Its
neurotoxic action results from blocking the sodium and
calcium post-synaptic ion channels and this, in turn,
blocks many inhibitory or hyper-polarization effects,
including -adrenergic, cholinergic, and purinergic
pathways. In neurons of both vertebrates and inverte-
brates, the post-synaptic ion channels play an important
role in repetitive activities, therefore apamine down-
stream action ultimately blocks these activities [12].
The mast cell degranulating (MCD) peptide is chem-
ically very similar to apamine and in fact it was found
to share the same 3=-exon [27]. It accounts for 2% of the
venom dry weight [3, 12] and comprises 22 amino acid
residues (MW  2.6 kDa). At low concentrations, MCD
causes mast cell break down, with a consequent mas-
sive release of histamine, thus contributing to the over-
all allergic reaction.
So far, researchers studying HBV have concentrated
their efforts on elucidating the properties of the aller-
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tion and characterization [21], on VIT [30], and on the
study of tissue damage from a physiological point of
view [31]. The study, isolation and characterization of
allergenic proteins and peptides are being performed
using much more sophisticated analytical techniques
including: gene cloning, mass spectrometry, X-ray and
genomic techniques [21]. In this context, MALDI mass
spectrometry has proven to be a powerful tool, espe-
cially when used in a typical bottom up proteomic
approach [9].
Recently, a new mass spectrometry technique named
matrix-assisted laser desorption/ionization mass spec-
trometry imaging (MALDI MSI) has shown great po-
tential for mapping a wide range of biomolecules (pep-
tides and proteins, drugs, lipids, metabolites) directly
from frozen tissue sections without the need for anti-
bodies or molecular probes [32–35]. Typically, a thin
tissue section is cut on a cryostat and spray coated with
an appropriate organic matrix. A raster of points is
defined and the laser (typically N2, Nd:YAG) will fire
on each of the points in the grid so that a set of mass
spectra will be acquired (microprobe mode). Each mass
spectrum, therefore, represents the local molecular
composition at known x,y coordinates. An ion image
can be obtained by simply retrieving via software the
m/z of interest [Francese, S.; Dani, F. R.; Traldi, P.;
Mastrobuoni, G.; Pieraccini, G.; Moneti, G. MALDI
Imaging Mass Spectrometry, from Its Origin Up
to Today: The State of the Art. CCHTS, in press];
the software will produce an ion image by plotting the
intensity of a selected m/z value as function of the
sampling position so that each image pixel correlates to
both a specific m/z value and to the corresponding
region of the original sample in which the analyte was
detected. The ion intensity is shown in the image as a
change in “brightness/hue” for each pixel.
Here, to the authors’ knowledge, for the first time
MALDI MSI has been applied to investigate the on
tissue direct detection of HBV upon honeybee sting. In
particular, three allergens (Api m 1, Api m 4, and Api m
6) and two neurotoxins (apamine and MCD) have been
monitored. The opportunity to explore a wide dynamic
molecular weight range allowed the authors to analyze
both the peptide and the protein fractions of the venom,
over different post-envenomation times. Specific proto-
cols are needed and are under current development to
map the distribution of the other allergens. Api m 2, Api
m 3, and Api m 7 are, per se, much higher molecular
weight biomolecules, to some extent glycosylated (Api
m 2, Api m 3), and in the case of Api m 3, also found as
a dimer [36, 37]. Finally, they represent altogether not
more than 5% to 6% of the honeybee venom, which
adds a further level of difficulty in their detection on
tissue.
An in vitro time course experiment has been de-
signed, using live honeybees to sting a 2 cm2 piece of
porcine skin (ear). Venom distribution was then
mapped within a transverse section of the skin. Also, asimilar in vivo experiment was carried out with live
animals (rats), that is, the “victim” was alive at the time
of the venom inoculation. Data obtained so far provide
the opportunity to map not only venom diffusion but
also the organism’s biochemical response. This possibil-
ity might open a new path for in vivo clinical trials in
designing and testing new VIT.
Experimental
Materials
Acetonitrile, trifluoroacetic acid (TFA) and formic acid
were purchased from Mallinckrodt Baker (Milan, Italy).
-Cyano-4-hydroxycinnamic acid (CHCA), ethanol,
methanol, dithiothreitol, DPX mountant, and Harris’s
modified haematoxylin and eosin solution (H and E)
were purchased from Sigma-Aldrich (Milan, Italy). Si-
napinic acid was obtained from Fluka (Milan, Italy).
Porcine ears were collected unsteamed from a local
abattoir (Arezzo, Italy). Honeybees (Apis mellifera) were
captured in the surroundings of the laboratory and kept
at constant temperature and humidity conditions with
sugary water ad libitum until used for venom extraction
and sting experiments. Conductive ITO glass slides
were obtained from Bruker Daltonics (Bremen, Ger-
many). Rats were purchased from Harlan, Udine, Italy.
Honeybee Venom Collection
Venom from one honeybee was collected with a capil-
lary by gently squeezing the venom sack. It was then
diluted in 50 L of double distilled water. The sample
was then centrifuged and the supernatant recovered
and dried in a vacuum centrifuge (Thermo Fisher, San
Jose, CA). The sample was reconstituted in 30 L of a
0.1% TFA solution.
Crude Honeybee Venom Extract Characterization:
MALDI MS and LC-ESI High Resolution MS
(LC-ESI/HRMS)
The crude venom extract was used to explore its com-
position through MALDI TOF MS and LC-ESI/HRMS.
First, the MALDI target plate was spotted with 1 L of
the sample and mixed in the well with either 1 L of 10
mg/mL of -cyano-4-hydroxycinnamic acid (CHCA)
dissolved in 70/30 acetonitrile/TFA 0.1%, or 1 L of 10
mg/mL of sinapinic acid dissolved in 70/30 acetonitrile/
TFA 0.1%. After complete drying, the samples were sub-
mitted to mass spectrometry analysis on a MALDI TOF
TOF Ultraflex III (Bruker Daltonics, Germany), which was
operated in positive reflectron and positive linear mode
for peptide and protein analyses respectively. The pep-
tidic fraction of the venom was acquired in the range m/z
100–4000 and calibrated using the Bruker peptide cali-
brant kit (m/z 1000–3500), whilst the protein fraction was
analyzed in the range 6000–50,000 m/z using the protein
calibrant Bruker kit II (m/z 18,000–66,000).
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submitted to LC-ESI/HRMS analysis by using an Ulti-
mate 3000 HPLC system (Dionex, Sunnyvale, CA) cou-
pled to a LTQ-Orbitrap mass spectrometer (Thermo
Fisher, San Jose, CA). A C4 Vydac column (150 mm 
300 m, 300 Å pore size) was used, operating a linear
gradient ramping from 5% A (0.1% aqueous formic
acid) to 60% B (95/5 acetonitrile/0.1% aqueous formic
acid) in 30 min. Data were acquired in a range m/z
500–2000 with a nominal resolution of 30,000 (at m/z
400) in data dependent acquisition, where the first and
then the second most intense ions from the MS scan
were selected for fragmentation. Data were processed
by using the Xcalibur software with the “Xtract” tool for
the calculation of deconvoluted average and monoiso-
topic molecular weight.
Simulation of Honeybee Sting
In vitro experiments. Four pieces of pig ear and four
live honeybees were selected for a single “in vitro” time
course experiment. A honeybee was placed adjacent to
the porcine skin and held in place using forceps. The
defensive instinct induced the honeybee to sting the skin.
A time course experiment in which the sting was left in
the piece of pig ear for a minimum time of 1 min to a
maximum of 120 min (1, 30, 60, 120, min) was performed.
At the end of each time point, the tissues were stored in a
80 °C freezer until further analysis. Each time point
experiment was repeated three times.
In vivo experiments. Two Wistar rats and two honey-
bees were used for a single in vivo time course enveno-
mation experiment. Ethical approval was obtained from
the Institutional Animal Care and Use Committee,
University of Florence, Italy, before starting the exper-
iments. No suffering was inflicted on the rats at each
experimental stage. The rats, ranging in weight from
290 to 400 g, were anesthetized with 1 to 2 doses of
chloral hydrate (400 mg/kg i.p.). When asleep, they had
a posterior leg carefully shaved, and they were kept
under anesthesia until sacrificed. The honeybees were
forced to sting the leg in the same fashion as in the in
vitro experiments. A simple time course experiment
was outlined so that rats were sacrificed by decapitation
at 1 min and 120 min after the envenomation event.
Each time point experiment was performed in
duplicate.
Tissue Staining
Tissue sections, cut consecutively to those destined for
MALDI MSI analysis, were subjected to a fast H and E
staining protocol. Briefly, sections were fixed in ethanol
at decreasing percentages (1 min in 100% ethanol, 1 min
in 90% ethanol, 1 min in 70% ethanol). Five seconds
washing in water was followed by 1 min immersion in
haematoxylin. The glass slides were then placed in
running tap water to remove excess haematoxylin untilthe water ran clear (about 3 min). Subsequently, the
tissues were stained for 30 s in eosin followed by a 5 s
wash in water, 30 s fixation in 70% ethanol, 1 min in
90% ethanol, and 1 min in 100% ethanol. After drying,
slides were mounted with coverslips by using DPX.
Mapping HBV Peptides and Proteins by MALDI
MSI
Porcine ear tissue sections (10 m thick) were cut by
using a cryostat kept at 30 °C and were then thaw-
mounted on ITO coated conductive glass slides. Sec-
tions destined for peptide MALDI MSI were imme-
diately placed in a vacuum dessicator for 30 min.
Sections to be subjected to protein MSI were washed
in 70% ethanol for 1 min, 90% ethanol for 30 s, and
subsequently immersed for a further 30 s in a solution
of 20 mg/mL of sinapinic acid in 90/10 ethanol/
0.1%TFA and then dried for 15 min in a vacuum
dessicator. Finally, dried sections were sprayed by
means of an airbrush (Eclipse HP-CS; Turin, Italy)
attached to a N2 line, with either 20 mL of 20 mg/mL
of -cyano-4-hydroxycinnamic acid (CHCA) dis-
solved in 50/50 acetonitrile/TFA 0.1% (for peptide
MALDI MSI), or 25 mL of 25 mg/mL of sinapinic acid
dissolved in 50/50 acetonitrile/TFA 0.2% (for protein
MALDI MSI). Two passes per spray cycle were used
and 30 s were allowed between cycles. The sections
were finally dried in a vacuum dessicator for 10 min
before MALDI MSI analysis. Matrix delocalization
was minimized and image reproducibility was ob-
served in serial sections from the same specimen by
keeping constant both the N2 pressure and the dis-
tance between the sections and the airbrush spray
nozzle.
The HBV peptidic fraction was mapped by using
an Ultraflex III MALDI TOF/TOF mass spectrometer
(Bruker Daltonics, Bremen Germany), in the range
m/z 100–4000. The instrument was operated in posi-
tive reflectron mode and the spatial resolution was
set to 300 m. The ion sources 1 and 2 were set to
25,000 and 21,500 V, respectively, with the delay time
at 60 ns. The HBV protein fraction was investigated in
a range between m/z 6000 and 50,000 in positive linear
mode; the delay time was increased to a value of 200
ns. Mass spectra acquisition was performed by using
the software Flex Imaging 2.0 and Flex Control 3.0
(Bruker Daltonics) and data processed through Flex
Imaging 2.0, Flex Analysis 3.0, and Biomap 3.7.5
(Novartis, Basel, Switzerland) software. Calibration
was performed before analysis, depositing either 0.5
L of crude venom mixed 1:1 with the appropriate
matrix and placed 0.5 cm away and on the left hand
side of the area affected by the sting. The m/z values
of Api m 4, apamine, MCD, Api m 1, and Api m 6
retrieved in the crude venom were used as calibration
points for MALDI MSI analysis of HBV peptides and
proteins. Normalization through Flex Imaging 2.0
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Mass to charge values for image display were se-
lected with a mass window of 1 Da for peptides and
5 Da for proteins. When Biomap 3.7.5 was used to
process the images, ion signals were normalized
against the sodium adduct of CHCA (m/z 212).
Evaluation of HBV Detection Limits in
MALDI MSI
Venom from 30 honeybees was collected and pooled,
then dried, weighed, and finally dissolved in 21 L of
an aqueous solution of 0.1% TFA, so that the final
concentration of the venom was 102 g/L. Aliquots of
2 L of this solution were prepared to obtain concen-
trations of 50.1, 10.2, 1.02, and 0.102 g/L. A pig ear
tissue section was spotted with 0.2 L of each of the
above solutions. This effectively resulted in depositing
20.4 g, 10.0 g, 2.04 g, 204 ng, and 20.4 ng of venom
on the pig skin section. Once dried, the tissue section
was spray-coated with CHCA matrix for peptide
analysis and subjected to MALDI TOF profiling exper-
iments. In this analysis, circular areas of 700 m diam-
eter, corresponding to the diameter of the deposited
venom droplet, were selected for laser firing. Five
sections (replicates) were submitted to this experiment
to compensate for any variability in response due to
non-homogeneous matrix deposition and local tissue
suppression effects.
Results and Discussion
Honeybee venom (HBV) is one of the best characterized
venoms amongst hymenoptera. Its composition, isola-
tion, characterization, and the cloning of its bioactive
species induced physiological damages and use in
therapeutic treatments, are some of the aspects so far
investigated [9, 22, 38, 39].
Here, the use of a novel technology named MALDI
MSI is applied to the detection of HBV in envenomed
tissues. A time course MALDI MSI experiment was
designed and performed to establish whether the
venom components were detectable and their limits of
detection as well as their diffusion behavior within the
tissue over time. In particular, two toxins (apamine and
MCD) and three allergens (Api m 4, Api m 6, and Api
m 1) were investigated. Molecular mass images of
venom distribution were obtained for all of these bi-
omolecules, showing the potential of this technology for
further and more in-depth studies of venom action and
the organism’s response.
A preliminary structural characterization was per-
formed to find the most readily detected HBV molecu-
lar species by using MALDI TOF MS and LC-ESI/
HRMS. In particular, optimal instrumental conditions
were determined to enhance ionization of the interested
biomolecules in MALDI MSI.HBV Characterization
Peptide range. Among honeybee venom peptides, the
most popular and characterized neurotoxins are apam-
ine and MCD. Api m 4, although being a peptide, is
actually considered a minor allergen. A simple charac-
terization of the crude venom extract, in particular of its
peptidic fraction, by MALDI TOF MS allowed the
detection of these three species atm/z of 2026.82, 2586.53
and 2845.63, respectively, in agreement with the theo-
retical m/z value; apamine has two disulphide bridges
and an amidated C-terminal histidine residue [40], thus
protonated apamine has a theoretical monoisotopic m/z
of 2026.86. MCD also has two disulphide bridges and an
amidation at the C-terminal asparagine residue [27],
thus exhibiting a theoretical monoisotopic m/z of
2586.38. Processed Api m 4 exhibits an amidation at the
C-terminal glutamine residue and has a theoretical
monoisotopic m/z of 2845.74 [6].
Protein range. The MALDI MS analysis of the HBV
protein fraction was performed using either CHCA or
sinapinic acid as matrices, obtaining complementary
information. An ion signal at m/z 7589.3 was found that
could correspond to the MW of the protein Api m 6, in
particular to the isoform Api m 6.03 (average MW
7588.1 Da). No other isoforms of this allergen were
detected by conventional MALDI MS analysis. Api m 1
was also detected in the MALDI MS analysis of the
crude venom extract. An ion signal at m/z 15,240.2 was
in fact observed (15,239.2 Da is the theoretical average
MW through cysteine linked disulphide bridges). This
ion signal was accompanied by a rich population of
other peaks distributed around 16.3 kDa and possibly
related to micro heterogeneous Api m 1 glycosylation.
Scheme 1 shows the possible glycostructures observed,
which agree with those reported by Shipolini and
collaborators [15] and Hollander et al. [41]. Higher m/z
protein signals were also detected (up to 50 kDa) but the
intensity and the resolution were too poor to proceed
with any m/z assignment.
The LC-ESI/HRMS analysis on the crude HBV ex-
tract gave the accurate MW of the intact HBV protein
species, thus supporting their detection via MALDI
TOF MS analysis and enabling the detection of other
isoforms. In particular for this analysis, Scheme 1 re-
ports the allergen Api m 6 detected at 6913.4 Da as 8–71
(theoretical monoisotopic MW 6913.4 Da), at 7174.5 Da
as 5–71 (Api m 6.01, theoretical monoisotopic MW
7174.5 Da), and at 7384.7 Da as 5–73 (Api m 6.02,
theoretical monoisotopic MW 7384.7 Da). In the LC-
ESI/HRMS experiments, Api m 1 was detected as a
secreted protein with no glycosylation at an average
MW of 15,239.0 Da and at a monoisotopic MW of
15,229.017 Da (15,229.022 Da is the theoretical monoiso-
topic MWwith cysteine linked disulphide bridges). The
presence of at least four potential Api m 1 glycoiso-
forms was also observed at a monoisotopic MW of
15,797.2, 15,959.3, 16,122.4, 16,284.4, and 16,674.4 Da as
117J Am Soc Mass Spectrom 2009, 20, 112–123 DETECTION OF HONEYBEE VENOM IN ENVENOMED TISSUESshown in Figure S1 of Supplemental Material, which
can be found in the electronic version of this article;
(15,807.3, 15,969.5, 16,131. 3, 16,293.8, and 16,683.2 Da
are the average MW respectively, reported in Scheme 1).
Thus, it was possible to confirm the presence of three of
the glyco-Api m 1 ion signals previously detected by
MALDI TOF MS, once again enhancing confidence in
the correct MALDI m/z attribution; this is, in turn, also
valuable both for calibration of the MALDI mass spec-
trometer instrument operating in MSI mode and for
post analysis recalibration.
The presence of the two neurotoxin peptides and
three allergens was further confirmed by a bottom up
approach on the venom tryptic digest, where the result-
ing peptidic mixture was submitted to shotgun pro-
teomic approach by MALDI TOF MS and MS/MS
analysis and LC-ESI HRMS/MS analysis.
In summary, the HBV has been characterized by
conventional MALDI MS analysis, by peptide mass
fingerprinting and MS/MS analysis, and finally by
LC-ESI/HRMS for accurate MW determination. Figure
S1A, B, and C, (Supplemental Material) show an over-
Scheme 1. Api m 6 and Api m 1 detection by mass spectrometry.
The MW and m/z values detected for Api m 1 and Api m 6 along
with their isoforms are reported. The venom was extracted and
analyzed by MALDI TOF MS conventional analysis (column 2)
and LC-ESI/HRMS analysis (column 3). Data deconvolution, from
the latter, generated average and monoisotopic MW, but only the
average mass values are reported here. MALDI MSI experiments
performed on the envenomed tissue allowed the detection of both
Api m 1 and Api m 6 (column 4). Primary sequence and the
glycosylated structure linked to the protein are reported for Api m
6 and Api m 1 isoforms, respectively. Monosaccharide residues
are depicted as follows: fucose residue as a triangle, mannose/
galactose residue as a circle, N-acetylglucosamine residue as a
square.view of the global characterization strategy followed inthis study, including examples of analysis for Api m 4,
Api m 6, and Api m 1, respectively.
Evaluating Venom Detection Limits in MALDI
MSI
MALDI MSI is undoubtedly very informative from a
qualitative point of view; nonetheless the feasibility of
quantitative analysis is very much debated (as expected
dealing with MALDI MS) and it is regarded as a
weakness of this technique. Whether a signal is not
detected because the species is not present, or is beyond
the detection limit, appears to be, for MALDI MSI in
particular, a dilemma. Indeed, this technology may
exhibit lower sensitivity in comparison to conventional
MALDI MS application; this is because ion suppression
(often selective) might be caused not only by the matrix
but also by the presence of salts and the tissue itself. In
the present study, the authors evaluated MALDI MSI
detection limits by monitoring HBV components in
envenomed tissues.
HBV was spotted at decreasing concentrations on a
10 m tissue section from pig ear sample, which was
then spray coated with CHCA to simulate its deposi-
tion in conventional imaging analysis. Five replicates
were analyzed and processed; factors including uneven
matrix distribution, tissue specific suppression, and
suppression due to competitive ionization were then
taken into account and normalized. HBV was deposited
only in the region between the epidermis and the
cartilage (where the venom is mostly detected); results
obtained relate exclusively to this area and are not
applicable, without further investigation, to other tissue
regions or to different tissue types. Even within the
same tissue, in fact, structurally different regions may
have different ion suppression effects, thus influencing
ionization yields. Only the HBV peptidic components
(apamine, MCD, and Api m 4) were considered for this
analysis. This choice was primarily made by consider-
ing the characteristics of Api m 4. It in fact has a
molecular weight of only 2.8 kDa, it exhibits a very
good ionization yield and it represents 45% to 50% of
the venom dry weight. It is then reasonable to hypoth-
esize that, for concentrations at which it is not detect-
able, it would be unlikely that higher molecular weight
proteins, expressed in less than 10% of the venom dry
weight, would be detected. On the basis of the amount
of venom deposited and the percentage of Api m 4 (45%
to 50%), apamine (1% to 2%), and MCD (1% to 2%)
contained in it [12], it was possible to estimate the
amount of these peptides deposited on the tissue (Table 1).
Api m 4 exhibits the maximum ion intensity when
spotting 2.04 g of venom (1/10 dilution of the original
stock solution, 10.2 g/L); here the absolute amount
of Api m 4 was calculated to be 0.92–1.02 g; Figure S2
(Supplemental Material) shows a set of Api m 4 MALDI
MS spectra for one replicate as an example. The same
trend is observed for MCD (absolute amount corre-
10.2
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Apamine maximum intensity is variable in the repli-
cates: it is observed when spotting both 2.04 and 10.0 g
of venom corresponding to 1/2 and 1/10 dilution of the
original stock solution (absolute amount deposited,
20.4–40.8 ng and 0.10–0.20 g, respectively); nonethe-
less the highest intensity is observed at the 1/2 dilution;
generally, the maximum HBV concentration used did
not produce the most intense signal. This is in agree-
ment with the very nature of MALDI ionization, where
the matrix/analyte ratio is crucial for maximum ioniza-
tion yields. As for the detection limits, data show that
with the lowest HBV amount spotted in MALDI Imag-
ing experiments, Api m 4 could still be easily detected
(9.2–10.2 ng, 6.8 pmol) in the five replicates, whereas
for apamine and MCD the approximate detection limit
is 0.2–0.4 ng on tissue. Figure S3 (Supplemental Mate-
rial) summarizes results for the three peptides in two
graphs, where the average ion intensity for each species
is plotted versus the aliquot concentration from which 1
L of venom was withdrawn and spotted. Considering
the amount of HBV injected per sting reported by
Freeman and coworkers [31] (50 g), the minimum
amount of Apamine and MCD detected is 3 orders of
magnitude lower than the actual amount contained in
the venom (considering that they are present at 1%); the
minimum amount of Api m 4 detected in the analysis,
corresponds to 4 orders of magnitude lower than the
actual amount contained in the volume of the venom
delivered by a single sting (considering Api m 4 is
present as 45%). Conclusively, considering the
amounts of venom spotted in this experiment, the
MALDI MSI detection limits were 9.7 ng for Api m 4
and 0.2–0.3 ng for apamine and MCD; this analysis
was considered satisfactory for the purpose and the
detection limits suitable for HBV MALDI MSI analysis.
MALDI MSI Analysis of Envenomed Tissues
In vitro analysis using honeybees and porcine ears. The
MALDI MSI analysis of the HBV peptidic fraction
proved to be successful in mapping HBV within a
biological tissue following a honeybee sting at different
time intervals. The shortest time point of 1 min was
chosen because it had previously been reported that in
both rabbit skin and various artificial media, the sting
embedded itself progressively deeper over a period of
Table 1. Amount of HBV spotted on tissue
Amount of
venom deposited Api m 4 a
102 20.4 g 9.2–
50.1 10.2 g 4.6–
10.2 2.04 g 0.92–
1.02 204 ng 91.8–
0.102 20.4 ng 9.2–30 s; at the end of this period, at least two-thirds of itslength was embedded [4] and venom inoculation is
thought to start at this time.
It is important to bear in mind that this is not a time
course experiment in real terms. Different pig ear
samples were used, which were then stung and left to
incubate for different time periods. The tissue morphol-
ogy, compactness, and thickness of the different skin
layers were observed to vary by histological inspection
so that a precise estimation of venom diffusion at
different times by simple comparison is not correct;
nonetheless MS images of apamine, MCD, and Api m 4
were obtained clearly showing their localization within
the tissue. Figure 1a shows, as an example, the H and E
histological image of a 10 m section cut from a porcine
skin sample stung by a honeybee (as a preliminary
experiment, 5 min were allowed to pass before freezing
and slicing the ear tissue). This section was the serial
section to the one submitted to MALDI MSI. Five min
mount
Apamine
abs. amount
MCD abs.
amount
g 0.20–0.40 g 0.20–0.40 g
g 0.10–0.20 g 0.10–0.20 g
g 20.4–40.8 ng 20.4–40.8 ng
g 0.92–1.84 ng 0.92–1.84 ng
ng 0.2–0.40 ng 0.2–0.40 ng
Figure 1. Tissue optical and MALDI MS images at 5 min
post-envenomation. A and E histological image of a 10 m pig ear
section shows an irritated (darker) area (a); by using the Flex
Imaging 3.0 software, MALDI MS image of Api m 4 (m/z 2845) was
superimposed showing that the irritated area is, in fact, character-bs. a
10.2
5.1 
1.02
102 nized by the presence of this allergen (b).
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already observed. This area was presumably affected by
the presence of the diffused venom and this hypothesis
was confirmed by the superimposition of the Api m 4
MS image on the histological one (Figure 1b). As
anticipated, the presence of the venom in the tissue was
observed throughout the time course MALDI MSI ex-
periment (analysis at 1, 30, 60, and 120 min post-
envenomation, Figure 2). Apamine, MCD and Api m 4
MS images are shown in Figure 2 as superimposed with
the MS image of phosphatidylcholine (m/z 184). This
facilitates visualization of the section and the relative
spatial distribution of the peptides. Although neither
venom quantitation nor a precise estimation of the
tissue total area infiltrated by the venom over time was
at this stage feasible, it was possible to observe a general
Figure 2. MALDI MS images of HBV peptide
maps of Apamine, MCD, and Api m 4 at 1, 30, 60
MS images were normalized against the CHC
shows the peptide MS images (in color) superimp
184, gray scale) to visualize the tissue section an
m 4 within it.trend showing a progressive decrease in the detection
of the HBV peptides over time.
Bioactive HBV peptides are readily mapped at 1 min
post-envenomation. In particular, Api m 4 is detected at
1 min post-envenomation, it is then observed to spread
after 30 min, and seems to accumulate in the proximity
of the cartilage 60 min after the envenomation event;
this accumulation might be due to the cartilage possibly
acting, somehow, as a barrier to the longitudinal diffu-
sion. Figure S4 (Supplemental Material) shows the
superimposition of the MS images with the histological
images of the tissue section thus supporting this last
observation.
MCD and apamine were also detected in the MALDI
MSI experiment and had the same ratios of intensity
peak intensity proportions, as that observed in conven-
using the Biomap 3.7.5 software, distribution
120 min post-envenomation were obtained. The
dium adduct (m/z 212) distribution. The figure
with the MS image of phosphatidylcholine (m/z
spatial distribution of Apamine, MCD and Apis. By
, and
A so
osed
d the
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suggests that if the tissue is causing ion suppression,
this event is not selective toward any specific peptide in
particular. MCD distribution maps over time show
detection at 1 min, a marked longitudinal diffusion at 30
min, with high density at the bottom of the image
belonging to MCD longitudinal diffusion; once again,
the maximum area affected is retrieved at 60 min
post-envenomation. Finally, Apamine is readily de-
tected after 1 min post-envenomation and seems to
undergo accumulation at 60 min as with Api m 4; the
apamine signal exhibits the same general trend as that
for MCD, the only difference being that the ion signal is
generally more intense. At 120 min post-envenomation,
localization maps for the three peptides are consider-
ably reduced, although Api m 4 and MCD are largely
detected also within the cartilage; apamine might not be
as well-detected in that area if the cartilage exerts a
selective ion suppression towards this ion. Since the
tissue was not viable at the time of the experiment, the
hypothesis that peptides were degraded by the tissue
was, in the first instance, ruled out; there could be other
reasons for the observed reduction in signal detection.
Over time, HBV peptides progressively diffuse and,
therefore, they might reach a concentration below the
Figure 3. MALDI MS images of allergen Api
isoforms at 30 min post-envenomation along
illustrated. Api m 6 MALDI images (in color) we
at m/z 11,233 (grey scale), which localizes across
allows visualization of the section, of the cartilag
6 relative spatial distribution.detection limits. The increased diffusion could also lead
to a ratio analyte/matrix value, which falls outside the
minimum for detection.
MALDI MSI analysis on the protein fraction of HBV
also showed very interesting results, including insights
into the structure of the allergens studied (Api m 6 and
Api m 1). MALDI MSI time course analysis on the
HBV protein fraction allowed mapping of the Api m
6 (mature protein MW 7588.1 Da) and Api m 1
(mature protein MW 15,239.2 Da) distribution, and
confirming a few features of their heterogeneous
nature, due to misassembly and the presence of
glycoisoforms, respectively.
In particular, MALDI MSI analysis revealed a more
heterogeneous composition for Api m 6 than that re-
ported. It is known, in fact, that Api m 6 comprises 4
isoforms: 1–71 (Api 6.01), 1–73 (Api m 6.04), 5–71 (Api m
6.03), and 5–73 (Api m 6.02), which are all allergenic [20].
Upon MALDI MSI of the 30 min post-envenomation
tissue, co-localizedmolecular images of Apim 6.01, Api m
6.0, and Api 6.04 were obtained (Figure 3). Figure 3
reports Api m 6 MS images superimposed with the
MS image of a protein at m/z 11,233, which is distrib-
uted throughout the section except in the cartilage.
This aids in visualization of the section, the cartilage
. Detection and distribution maps of Api m 6
the corresponding MALDI MS spectrum are
perimposed with the MALDI image of a protein
hole tissue section, except in the cartilage. This
gative image), and a better evaluation of Api mm 6
with
re su
the w
e (ne
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of Api m 6. By retrieving the MS spectrum associated
with the highest pixel intensity of isoform Api m 6.03,
it was observed that, besides those isoforms, the
spectrum exhibited two other interesting signals at
m/z 7741.6 and 7385.0 related to Api m 6 sequence:
2–71 and 3–71 (Figure 3). A very low intensity peak
(S/N 1.7) at m/z 6919.3 also revealed the presence of
isoform 8–71 (Figure S5, Supplemental Material). It is
important to bear in mind that Api m 6 is not
reported to be subjected to any modification upon
venom inoculation and interaction with the tissue
[20]; this is confirmed by the observation that most of
the above species were present in the crude venom
extract (Scheme 1).
This multi-isoform detection adds a further level of
complexity to the expression of this allergen, which
seems to exhibit a much higher degree of misassembly,
and it would be interesting to investigate whether or
not these newly discovered forms are also allergenic.
Another interesting observation can be made by exam-
ining the MS images reported in Figure 3; in contrast to
the work of Kettner et al. [20], which suggested that Api
m 6 isoforms are present in approximately equimolar
amounts, the MALDI MSI analysis found that Api m
6.02 was not detected, whilst Api m 6.04 exhibited a
remarkably lower density map compared with Api m
6.03 and Api m 6.01, which are the only two isoforms
with comparable ion density distributions. Although
the MALDI ionization yield is not proportional to
concentration, since those three isoforms co-localize
and are not significantly structurally different, it would
be hard to invoke a differential and substantial ioniza-
tion yield or a specific tissue suppression to justify such
a remarkable difference in the density maps; it is
therefore hypothesized that these isoforms may, in fact,
not be present in equimolar amounts.
Exploring the area where Api m 6 was distributed,
co-localization of Api m 1 signal at m/z 15,240 was
Figure 4. MALDI MS images of allergens Api m
post-envenomation are shown. Api m 6 and Ap
digital scan of the tissue section, thus allowing
distribution.observed, as shown in the corresponding MS spectrum
extracted from the MALDI MSI run (Figure S5). Three
other ion signals at m/z 15,971, 16,116, and 16,846 were
detected in that area and were compatible with three
Api m 1 isoforms exhibiting different glycation levels
(Scheme 1).
The MALDI MSI time course on the HBV protein
fraction produced images of Api m 1 and Api m 6 at
30 and 60 min post-envenomation (Figure 4). In
Figure 4, Api m 1 and Api m 6 MS images are shown
superimposed with the digital scan of the tissue section,
thus allowing a better evaluation of Api m 6 relative
spatial distribution. At 30 min post-envenomation,
Api m 6 and Api m 1 exhibited a similar diffusion
pattern, which is also very different from the one
observed for HBV peptides, appearing much less
diffuse.
The MALDI MSI time course experiment consis-
tently failed to produce distribution maps for Api m 6
and Api m 1 allergens, both at 1 min and 120 min
post-envenomation. One possible hypothesis to test
further could simply be that at 1 min the venom has
not been fully inoculated and spread sufficiently for
the Api m 1 and Api m 6 ion signals to fall within the
detection limits of the instrument; at 120 min the
opposite situation (venom spreading and greater
diffusion) may cause the same result where allergen
concentration is insufficient to be detected. Indeed,
already at 60 min post-envenomation, the areas in
which Api m 6 and Api m 1 were observed are
considerably reduced compared with those observed
at 30 min post-venom inoculation.
In vivo experiments using honeybees and rats. An in vivo
analysis of envenomed tissues was also attempted to
prove the potential of MALDI MSI to simultaneously
map venom action and organism response. Initial ex-
periments were performed using anaesthetized rats
instead of pig ears in a similar fashion to previously
nd Api m 1. Distribution maps at 30 and 60 min
1 MALDI images were superimposed with the
tter evaluation of the allergen’s relative spatial6 a
i m
a be
histo
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assessed analyzing tissues after 1 and 120 min from the
sting event. Results were encouraging but also high-
lighted areas for improvement; data showed that the in
vivo MALDI MSI analysis of envenomed tissues gener-
ally yields HBV ion signals of lower intensity. The ion
images showed a rational localization within the tissue
but the venom was observed in smaller areas compared
with those observed in the pig ear samples at the same
time points. Api m 4, apamine, and Api m 6 were
detected at 1 min, although the diffusion in rat muscle
seemed to be more contained around the sting, com-
pared with that observed in the porcine sample (Figure 5);
at 120 min post-envenomation detection is extremely
poor. Apamine and Api m 4 were detected in only six
positions whilst Api m 6 was no longer observed,
whereas Api m 1 was detected (data not shown). For
results at 1 min and 120 min, it can be hypothesized that
in these cases, besides diffusion, the tissue components
may play a role; being biologically active at the time of
the sting event, it could react to the venom leading to
degradation. To confirm whether it is diffusion or
degradation that leads to the observed effects requires
further investigation.
In an attempt to detect a tissue response to HBV, a
Figure 5. MALDI MS images of Apamine, Ap
experiment. Distribution maps within the enven
superimposed with the correspondent H and E
Figure 6. MALDI MS images of the tissue bioch
H and H histological image of the rat leg muscle
the sting) along with the MS images of two sul
cytokine (IL-4) at 1 and 120 min post-envenomation.more careful exploration of the mass range between
10–25 kDa (protein m/z range) and 300–900 Da (lipid
range) was carried out. MALDI MSI and MALDI MS
data processing revealed the presence of the sulphido-
leukotrienes LTC4 and LTD4 at m/z 497.2 and 624.3,
respectively (theoretical MW 496.3 and 623.3 Da), as
shown in Figure 6 (upper panel). Sulphidoleukotrienes
are important markers of an inflammatory event such
as the one caused by HBV sting. At 1 min post-
envenomation they were found nicely co-distributed
with the sting, which was left within the tissue, and in
close proximity. At 1 min post-envenomation, an ion
signal at m/z 13,760, (Figure 6 upper panel) compatible
with the molecular weight of interleukin 4 (IL-4, theo-
retical MW of mature protein with one disulphide
bridge is 13,761 Da) was also detected (Figure 6, upper
panel). Although, the presence of IL-4 must be further
investigated and confirmed, this result would be in
partial agreement with the work of Mustafa and
coworkers [11], who reported the presence of sul-
phidoleukotrienes within 5 min of a sting, whilst IL-4
was induced at later time points. At 120 min post-
envenomation, the distribution maps for LCT4, LTD4,
and the putative IL-4 change (Figure 6, lower panel).
LTD4 appears much more widespread, whilst LTC4 is
4, and Api m 6 from the in vivo time course
tissue at 1 min post-envenomation are shown
logical images.
al response to envenomation. Figure reports the
ion (the arrows indicate the original position of
oleukotrienes (LTC4 and LTD4) and a putativei m
omedemic
sect
phid
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area close to the sting.
Conclusions
The work described in this paper demonstrates the
ability of MALDI MSI to provide molecular maps of
HBV in envenomed tissues over time. This technology
offers the opportunity of monitoring, simultaneously,
HBV presence and diffusion over time, as well as
detecting the host organism response. This raises the
possibility that MALDI MSI could be used in the
preclinical trial stage development of more efficient
venom immunotherapies, which in the future could be
tailored to individuals.
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